Patents Assigned to Corridor Pharmaceuticals, Inc.
  • Arginase inhibitors and methods of use thereof
    Patent number: 8894970
    Abstract: The present invention includes arginase enzyme inhibitors, compositions comprising these arginase inhibitors, and methods of treating or diagnosing conditions characterized either by abnormally high arginase activity or abnormally low nitric oxide levels in a mammal, comprising administering compositions of the invention to the mammal.
    Type: Grant
    Filed: July 26, 2011
    Date of Patent: November 25, 2014
    Assignee: Corridor Pharmaceuticals, Inc.
    Inventors: Bruce Edward Tomczuk, Gary Lee Olson, Richard Scott Pottorf, Lijuan Jane Wang, Bhaskara Rao Nallaganchu, Yanqun Zhang